Images

Filter by

Box 1 Risk Factors for Developing Hyperkalaemia3 4
Box 1: Risk Factors for Developing Hyperkalaemia3,4
Table 2 Comparison of MRI and PET Parameters Between Patients with Diabetes and Peripheral Artery Disease and Healthy Controls
Table 2: Comparison of MRI and PET Parameters Between Patients with Diabetes and Peripheral Artery Disease and Healthy Controls
Table 1 Clinical Characteristics of Patients with Diabetes and Peripheral Artery Disease and Healthy Controls
Table 1: Clinical Characteristics of Patients with Diabetes and Peripheral Artery Disease and Healthy Controls
Figure 3 Correlations Among MRI Ultrasound and PET Parameters
Figure 3: Correlations Among MRI, Ultrasound and PET Parameters
Figure 2 Results of Blood Oxygenation Level dependent Imaging Intravoxel Incoherent Motion Imaging and Arterial Blood Flow
Figure 2: Results of Blood Oxygenation Level-dependent Imaging, Intravoxel Incoherent Motion Imaging and Arterial Blood Flow
Figure 1 Flow Diagram of Scans Received by Patients with Diabetes and Peripheral Artery Disease and the Healthy Controls
Figure 1: Flow Diagram of Scans Received by Patients with Diabetes and Peripheral Artery Disease and the Healthy Controls
Figure 3 Antihypertensive Medication Use From 2017 to 2022
Figure 3: Antihypertensive Medication Use From 2017 to 2022
Figure 2 Percentage of Patients With Uncontrolled Hypertension Per Guideline from 2017 to 2022
Figure 2: Percentage of Patients With Uncontrolled Hypertension Per Guideline from 2017 to 2022
Figure 1 Prevalence of Hypertension Per Guideline from 2017 to 2022
Figure 1: Prevalence of Hypertension Per Guideline from 2017 to 2022
Table 1 Overall Prevalence of Hypertension Based on the 2017 American College of Cardiology American Heart Association 2023 European Society of Hypertension and 2020 Philippine Guideline Classification
Table 1: Overall Prevalence of Hypertension Based on the 2017 American College of Cardiology/American Heart Association, 2023 European Society of Hypertension and 2020 Philippine Guideline Classification
Figure 1 Simplified Pathophysiology Linking Obesity and Heart Failure
Figure 1: Simplified Pathophysiology Linking Obesity and Heart Failure
Table 1 Glucagon like Peptide 1 Receptor Agonists in Heart Failure Key Relevant Trials
Table 1: Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Key Relevant Trials